US EditionPublished • loading... • Updated
Can Switzerland Be the Brain of Pharma without Producing Medicines?
Summary by Le Temps
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
As many countries increasingly aspire to the manufacture of medicines on their soil, Switzerland runs the risk of turning into a major research and development laboratory. A risky trend, warns representatives of the Basel pharma gathered at the WEFA third of the 90,000 jobs in the life sciences sector are in the Basel agglomeration. That is to say, this region closely follows the every act and gestures of Donald Trump's administration relating t…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
